Advair is a prescription inhaler used to treat asthma and chronic obstructive pulmonary disease (COPD). It combines two medications in a single device: one that reduces inflammation in the airways and another that keeps them relaxed and open. It’s taken twice daily as a maintenance treatment, meaning it’s designed to prevent symptoms over time rather than provide quick relief during an attack.
Conditions Advair Treats
Advair is FDA-approved for two primary conditions. For asthma, it’s approved as a twice-daily maintenance treatment in patients aged 4 and older. For COPD associated with chronic bronchitis, it’s used as ongoing maintenance therapy in adults. In both cases, the goal is the same: reduce the frequency and severity of breathing difficulties by keeping inflammation down and airways open around the clock.
One important distinction is that Advair is not a rescue inhaler. It won’t stop an asthma attack or a sudden episode of shortness of breath that’s already happening. People using Advair still need a separate fast-acting inhaler for those situations.
How the Two Ingredients Work Together
Advair’s effectiveness comes from pairing two drugs that attack breathing problems from different angles. The first ingredient is an inhaled corticosteroid that reduces inflammation. It works by suppressing the immune cells and chemical signals that drive the swelling, mucus production, and tightening inside your airways. Over days and weeks of consistent use, this calms the chronic irritation that makes asthma and COPD symptoms worse.
The second ingredient is a long-acting bronchodilator. It stimulates receptors on the smooth muscle surrounding your airways, triggering those muscles to relax. This physically opens the air passages and keeps them wider for about 12 hours per dose, which is why Advair is taken twice a day. The bronchodilator also helps prevent mast cells from releasing chemicals that trigger allergic-type reactions in the lungs.
Neither ingredient alone does the full job. The corticosteroid controls the underlying inflammation but doesn’t quickly open tight airways. The bronchodilator opens airways but doesn’t address the root inflammation. Together, they cover both problems simultaneously.
Available Strengths and Forms
Advair comes in two delivery systems. The Diskus version is a dry powder inhaler that you activate by breathing in. The HFA version is a pressurized metered-dose aerosol, similar to a traditional pump inhaler. Both deliver the same two active ingredients, but the devices feel different to use and come in slightly different strength options.
The Diskus is available in three strengths: 100/50, 250/50, and 500/50. The first number represents the corticosteroid dose in micrograms, and the second is the bronchodilator dose. For asthma in adults and adolescents 12 and older, any of the three strengths may be prescribed depending on severity. Children aged 4 to 11 are typically started on the lowest strength, 100/50. For COPD, the 250/50 strength is the standard dose.
Common Side Effects
The most frequently reported side effects in asthma clinical trials were upper respiratory tract infections (affecting 21% to 27% of patients), headaches (12% to 13%), and sore throat (10% to 13%). These overlap with symptoms people with respiratory conditions already experience, which can make it tricky to tell what’s caused by the medication versus the underlying disease.
A side effect worth knowing about is oral thrush, a yeast infection in the mouth and throat caused by the corticosteroid settling on soft tissue. In asthma trials, this affected 1% to 4% of patients, but in COPD trials the rate jumped to 10%. Rinsing your mouth with water after each dose and spitting it out significantly reduces this risk. Hoarseness is another corticosteroid-related effect, reported in about 2% to 5% of users.
Other side effects seen in trials at rates of 3% or higher include sinusitis, bronchitis, cough, nausea, muscle pain, and diarrhea. COPD patients also reported dizziness (4%), fatigue (3%), and muscle cramps (3%) at notable rates.
Serious Safety Concerns
Advair carries an FDA warning about its long-acting bronchodilator component. Medications in this class have been associated with an increased risk of serious asthma-related events, including hospitalization and, in rare cases, death. This risk is the reason Advair is generally reserved for people whose asthma isn’t adequately controlled on an anti-inflammatory inhaler alone, rather than used as a first-line treatment.
For COPD patients specifically, inhaled corticosteroids (including the one in Advair) have been linked to an increased risk of pneumonia. This is something to be aware of, particularly since COPD already raises pneumonia risk on its own. Any new or worsening cough, fever, or difficulty breathing while using Advair warrants prompt medical attention.
What to Expect When Starting Advair
The bronchodilator component begins working relatively quickly, helping open your airways within the first day or two. But the full benefit of Advair takes longer because the corticosteroid needs time to reduce chronic inflammation. Most people notice meaningful improvement within the first one to two weeks, with continued gains over several weeks of consistent use.
Because the medication works preventively, it needs to be taken every day on schedule, even when you feel fine. Skipping doses because symptoms have improved is one of the most common reasons people lose control of their asthma or COPD. The twice-daily schedule, roughly 12 hours apart, keeps both ingredients active in your system around the clock. If you miss a dose, take it as soon as you remember, but don’t double up.
Advair Diskus vs. Advair HFA
The Diskus is a breath-activated dry powder inhaler. You load a dose by sliding a lever, then inhale steadily and deeply. It doesn’t require you to coordinate pressing a button while breathing in, which many people find easier to use correctly. The HFA is a pressurized aerosol that sprays the medication as a fine mist. It requires more coordination between pressing the canister and inhaling, but some people prefer its feel or find it works better with a spacer device.
The choice between them often comes down to personal preference, ease of use, and which strengths are available for your condition. Both deliver the same active ingredients and treat the same conditions. If you struggle with the technique for one device, switching to the other can sometimes improve how much medication actually reaches your lungs.